vs

Side-by-side financial comparison of CME Group (CME) and Norwegian Cruise Line Holdings (NCLH). Click either name above to swap in a different company.

Norwegian Cruise Line Holdings is the larger business by last-quarter revenue ($2.3B vs $1.9B, roughly 1.2× CME Group). Norwegian Cruise Line Holdings runs the higher net margin — 4.5% vs 0.1%, a 4.4% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 9.6%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs -0.9%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Norwegian Cruise Line (NCL) is an American cruise line founded in Norway in 1966, headquartered in Miami-Dade County, Florida, and incorporated in the Bahamas. It is the fourth-largest cruise line in the world by passengers, controlling about 8.6% of the total worldwide share of the cruise market by passengers as of 2021. It is wholly owned by parent company Norwegian Cruise Line Holdings.

CME vs NCLH — Head-to-Head

Bigger by revenue
NCLH
NCLH
1.2× larger
NCLH
$2.3B
$1.9B
CME
Growing faster (revenue YoY)
CME
CME
+4.9% gap
CME
14.5%
9.6%
NCLH
Higher net margin
NCLH
NCLH
4.4% more per $
NCLH
4.5%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
-0.9%
NCLH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CME
CME
NCLH
NCLH
Revenue
$1.9B
$2.3B
Net Profit
$1.2M
$104.7M
Gross Margin
Operating Margin
0.1%
10.0%
Net Margin
0.1%
4.5%
Revenue YoY
14.5%
9.6%
Net Profit YoY
20.7%
EPS (diluted)
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
NCLH
NCLH
Q1 26
$1.9B
$2.3B
Q4 25
$1.6B
$2.2B
Q3 25
$1.5B
$2.9B
Q2 25
$1.7B
$2.5B
Q1 25
$1.6B
$2.1B
Q4 24
$1.5B
$2.1B
Q3 24
$1.6B
$2.8B
Q2 24
$1.5B
$2.4B
Net Profit
CME
CME
NCLH
NCLH
Q1 26
$1.2M
$104.7M
Q4 25
$1.2B
$14.3M
Q3 25
$908.0M
$419.3M
Q2 25
$1.0B
$30.0M
Q1 25
$956.2M
$-40.3M
Q4 24
$874.6M
$254.5M
Q3 24
$912.8M
$474.9M
Q2 24
$883.2M
$163.4M
Gross Margin
CME
CME
NCLH
NCLH
Q1 26
Q4 25
41.0%
Q3 25
47.1%
Q2 25
42.1%
Q1 25
38.7%
Q4 24
38.0%
Q3 24
45.2%
Q2 24
38.7%
Operating Margin
CME
CME
NCLH
NCLH
Q1 26
0.1%
10.0%
Q4 25
61.8%
8.3%
Q3 25
63.3%
25.5%
Q2 25
66.7%
16.8%
Q1 25
67.5%
9.4%
Q4 24
62.1%
10.2%
Q3 24
64.6%
24.6%
Q2 24
65.3%
14.4%
Net Margin
CME
CME
NCLH
NCLH
Q1 26
0.1%
4.5%
Q4 25
71.7%
0.6%
Q3 25
59.1%
14.3%
Q2 25
60.6%
1.2%
Q1 25
58.2%
-1.9%
Q4 24
57.3%
12.1%
Q3 24
57.6%
16.9%
Q2 24
57.6%
6.9%
EPS (diluted)
CME
CME
NCLH
NCLH
Q1 26
$0.23
Q4 25
$3.24
$0.08
Q3 25
$2.49
$0.86
Q2 25
$2.81
$0.07
Q1 25
$2.62
$-0.09
Q4 24
$2.40
$0.55
Q3 24
$2.50
$0.95
Q2 24
$2.42
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
NCLH
NCLH
Cash + ST InvestmentsLiquidity on hand
$2.4B
$185.0M
Total DebtLower is stronger
$3.4B
$15.2B
Stockholders' EquityBook value
$2.4B
Total Assets
$202.0B
$23.8B
Debt / EquityLower = less leverage
6.23×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
NCLH
NCLH
Q1 26
$2.4B
$185.0M
Q4 25
$4.5B
$209.9M
Q3 25
$2.6B
$166.8M
Q2 25
$2.1B
$184.0M
Q1 25
$1.5B
$184.4M
Q4 24
$3.0B
$190.8M
Q3 24
$2.4B
$332.5M
Q2 24
$1.9B
$594.1M
Total Debt
CME
CME
NCLH
NCLH
Q1 26
$3.4B
$15.2B
Q4 25
$13.7B
Q3 25
$13.6B
Q2 25
$12.6B
Q1 25
$12.9B
Q4 24
$11.8B
Q3 24
$11.8B
Q2 24
$11.9B
Stockholders' Equity
CME
CME
NCLH
NCLH
Q1 26
$2.4B
Q4 25
$28.7B
$2.2B
Q3 25
$28.2B
$2.2B
Q2 25
$27.7B
$1.6B
Q1 25
$27.0B
$1.4B
Q4 24
$26.5B
$1.4B
Q3 24
$28.2B
$1.1B
Q2 24
$27.6B
$693.1M
Total Assets
CME
CME
NCLH
NCLH
Q1 26
$202.0B
$23.8B
Q4 25
$198.4B
$22.5B
Q3 25
$187.1B
$22.2B
Q2 25
$179.9B
$21.6B
Q1 25
$157.8B
$21.4B
Q4 24
$137.4B
$20.0B
Q3 24
$137.8B
$19.8B
Q2 24
$123.4B
$20.1B
Debt / Equity
CME
CME
NCLH
NCLH
Q1 26
6.23×
Q4 25
6.21×
Q3 25
6.22×
Q2 25
8.05×
Q1 25
9.09×
Q4 24
8.26×
Q3 24
10.35×
Q2 24
17.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
NCLH
NCLH
Operating Cash FlowLast quarter
$811.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
16.3%
Cash ConversionOCF / Net Profit
7.75×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
NCLH
NCLH
Q1 26
$811.5M
Q4 25
$1.1B
$459.1M
Q3 25
$968.1M
$236.6M
Q2 25
$1.1B
$714.9M
Q1 25
$1.1B
$679.2M
Q4 24
$1.0B
$399.3M
Q3 24
$1.0B
$172.5M
Q2 24
$776.9M
$670.9M
Free Cash Flow
CME
CME
NCLH
NCLH
Q1 26
Q4 25
$1.1B
$21.5M
Q3 25
$949.7M
$-726.5M
Q2 25
$1.0B
$381.2M
Q1 25
$1.1B
$-846.0M
Q4 24
$991.7M
$155.8M
Q3 24
$973.2M
$-195.5M
Q2 24
$758.7M
$330.2M
FCF Margin
CME
CME
NCLH
NCLH
Q1 26
Q4 25
66.8%
1.0%
Q3 25
61.8%
-24.7%
Q2 25
61.5%
15.1%
Q1 25
67.1%
-39.8%
Q4 24
65.0%
7.4%
Q3 24
61.4%
-7.0%
Q2 24
49.5%
13.9%
Capex Intensity
CME
CME
NCLH
NCLH
Q1 26
16.3%
Q4 25
2.0%
19.5%
Q3 25
1.2%
32.8%
Q2 25
1.1%
13.3%
Q1 25
0.9%
71.7%
Q4 24
1.7%
11.5%
Q3 24
1.9%
13.1%
Q2 24
1.2%
14.4%
Cash Conversion
CME
CME
NCLH
NCLH
Q1 26
7.75×
Q4 25
0.96×
32.21×
Q3 25
1.07×
0.56×
Q2 25
1.03×
23.83×
Q1 25
1.17×
Q4 24
1.16×
1.57×
Q3 24
1.10×
0.36×
Q2 24
0.88×
4.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

NCLH
NCLH

Passenger ticket$1.5B66%
Onboard and other$788.9M34%

Related Comparisons